SINGLETON J MATTHEW
Insider CIK 1243514 · VKTX Director · CBST Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-05 | 20,400 | — | $0 | 20,400 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2026-01-02 | 2026-01-05 | 3,150 | — | $0 | 12,650 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2025-01-02 | 2025-01-06 | 18,800 | — | $0 | 18,800 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-10-25 | 2024-10-25 | 16,000 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-10-25 | 2024-10-25 | 16,000 | $4.48 | $71.7K | 25,500 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-10-25 | 2024-10-25 | 16,000 | $79.50 | $1.27M | 9,500 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-09-20 | 2024-09-20 | 10,300 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-09-20 | 2024-09-20 | 10,300 | $69.50 | $715.9K | 9,500 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-09-20 | 2024-09-20 | 10,300 | $1.19 | $12.3K | 19,800 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-08-21 | 2024-08-22 | 5,700 | — | $0 | 10,300 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-08-21 | 2024-08-22 | 5,700 | $69.72 | $397.4K | 9,500 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-08-21 | 2024-08-22 | 5,700 | $1.19 | $6.8K | 15,200 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-08-19 | 2024-08-19 | 16,000 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-08-19 | 2024-08-19 | 2,500 | $60.01 | $150.0K | 23,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-08-19 | 2024-08-19 | 3,047 | $61.13 | $186.3K | 19,953 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-08-19 | 2024-08-19 | 4,509 | $61.86 | $278.9K | 15,444 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-08-19 | 2024-08-19 | 2,055 | $63.15 | $129.8K | 13,389 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-08-19 | 2024-08-19 | 2,388 | $64.10 | $153.1K | 11,001 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-08-19 | 2024-08-19 | 1,501 | $64.88 | $97.4K | 9,500 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-08-19 | 2024-08-19 | 16,000 | $3.33 | $53.3K | 25,500 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-08-14 | 2024-08-14 | 20,786 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-08-14 | 2024-08-14 | 160 | $58.37 | $9.3K | 9,500 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-08-14 | 2024-08-14 | 20,786 | $8.00 | $166.3K | 30,286 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-08-14 | 2024-08-14 | 20,626 | $57.52 | $1.19M | 9,660 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2024-01-02 | 2024-01-04 | 32,000 | — | $0 | 32,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2023-01-03 | 2023-01-04 | 22,000 | — | $0 | 22,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 22,000 | — | $0 | 22,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 22,000 | — | $0 | 22,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2020-01-02 | 2020-01-03 | 22,000 | — | $0 | 22,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2019-01-02 | 2019-01-03 | 22,000 | — | $0 | 22,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | P Buy | 2018-05-31 | 2018-05-31 | 9,500 | $9.82 | $93.3K | 9,500 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2018-01-02 | 2018-01-03 | 16,000 | — | $0 | 16,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2017-01-03 | 2017-01-05 | 16,000 | — | $0 | 16,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2016-01-04 | 2016-01-06 | 16,000 | — | $0 | 16,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2015-04-28 | 2015-04-30 | 20,786 | — | $0 | 20,786 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2013-06-12 | 2013-06-14 | 1,104 | — | $0 | 1,104 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2013-06-12 | 2013-06-14 | 8,370 | — | $0 | 8,370 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-06-06 | 2013-06-11 | 1,347 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-06-06 | 2013-06-11 | 1,347 | — | $0 | 4,972 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-05-22 | 2013-05-22 | 10,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-05-22 | 2013-05-22 | 17,500 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-05-22 | 2013-05-22 | 10,000 | $9.56 | $95.6K | 13,625 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-05-22 | 2013-05-22 | 17,500 | $22.71 | $397.4K | 31,125 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2013-05-22 | 2013-05-22 | 27,500 | $55.48 | $1.53M | 3,625 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2012-08-24 | 2012-08-27 | 2,500 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2012-08-24 | 2012-08-27 | 2,500 | $45.52 | $113.8K | 3,625 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2012-08-24 | 2012-08-27 | 2,500 | $10.09 | $25.2K | 6,125 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2012-06-06 | 2012-06-11 | 1,347 | — | $0 | 1,347 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2012-06-06 | 2012-06-11 | 9,367 | — | $0 | 9,367 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2012-03-09 | 2012-03-12 | 10,000 | — | $0 | 2,500 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2012-03-09 | 2012-03-12 | 10,000 | — | $0 | 13,625 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2012-03-09 | 2012-03-12 | 10,000 | $43.06 | $430.6K | 3,625 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2012-02-03 | 2012-02-06 | 2,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2012-02-03 | 2012-02-06 | 2,000 | $42.28 | $84.6K | 3,625 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2012-02-03 | 2012-02-06 | 2,000 | $11.89 | $23.8K | 5,625 | SEC↗ |